Transfusion medicine and hemostasis : clinical and laboratory aspects / edited by Beth H. Shaz, Christopher D. Hillyer, Morayma Reyes Gil
Current Good Manufacturing PracticesLaboratory Laws and Regulations; Other Regulatory Agencies; Blood Banking; Chapter 4. Role of the Physician in the Blood Center; Blood Center Table of Organization; Donation Process; Chapter 5. Blood Donation; Blood Donors; Donation Process; Technical Aspects; Chapter 6. Apheresis Blood Component Collections; RBC Apheresis Collections; Plateletpheresis Collections; Plasmapheresis Collections; Chapter 7. Recipient-Specific Blood Donation; Exceptional Medical Need; Directed Donation; Autologous Donation; Chapter 8. Adverse Donor Reactions.
Complications of Whole Blood DonationComplications of Apheresis Donations; Approach to the Donor and Donation Process; Prevention; Biovigilance and Reporting; Component Manufacturing; Chapter 9. Component Preparation and Manufacturing; Whole Blood; Component Manufacturing; RBC Components; Plasma Components; Cryoprecipitate; Cryoprecipitate-Reduced Plasma; Platelet Components; Granulocytes; Component Labeling; Donor Testing; Chapter 10. Serologic Testing of Donor Products; ABO Group Typing; D Antigen Phenotype; Antibody Screening for the Presence of Unexpected RBC Antibodies.
Chapter 14. Hepatitis C Virus ScreeningDetermination of Need and Requirement for Testing; Donor Management; Chapter 15. West Nile Virus Screening; Determination of Need and Requirement for Testing; Donor Management; Chapter 16. Zika Virus Screening; Infection; Determination of Need and Requirement for Testing; Blood Unit Management; Donor Management; Chapter 17. Babesia Screening; Description; Infection; Determination of Need and Requirement for Testing; Blood Unit Management; Donor Management; Chapter 18. Syphilis, Human T-Cell Lymphotropic Virus, and Chagas Screening; Syphilis.
Intro; Title page; Table of Contents; Copyright; List of Contributors; About the Editors; Preface; PART I. Blood Banking and Transfusion Medicine; Chapter 1. Introduction to Blood Banking and Transfusion Medicine; Blood Transfusion History; Blood Industry; Discipline; Chapter 2. Quality Principles in Transfusion Medicine; Basic Principles; Quality Management Systems; Process Improvement; New Role of Quality; Chapter 3. Regulatory Issues in Transfusion Medicine; Regulation Versus Accreditation; The Food and Drug Administration; Registration and Licensure; Inspections and Compliance Actions.
Phenotyping RBC ProductsAntibody Titer Anti-A, Anti-B; International; Chapter 11. Overview of Infectious Disease Testing; Background; Approach to Testing; Determination of Need and Requirement for Testing; Selection of Testing Methodology; Biology of Infection and Testing Strategies; Product and Donor Management; Chapter 12. Human Immunodeficiency Virus Screening; Description; Determination of Need and Requirement for Testing; Blood Unit Management; Donor Management; Chapter 13. Hepatitis B Virus Screening; Determination of Need and Requirement for Testing; Donor Management.
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
Amsterdam, Netherlands: Elsevier ; 2018 |
Ausgabe: |
Third edition |
Reproduktion: |
Online-Ausg. |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shaz, Beth [HerausgeberIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
ISBN: |
---|
Anmerkungen: |
Includes index |
---|
Umfang: |
1 Online-Ressource (1 online resource) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1031901787 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1031901787 | ||
003 | DE-627 | ||
005 | 20240102203038.0 | ||
007 | cr uuu---uuuuu | ||
008 | 181002s2018 ne |||||o 00| ||eng c | ||
020 | |a 0128137274 |c : electronic bk. |9 0-12-813727-4 | ||
020 | |a 9780128137277 |c : electronic bk. |9 978-0-12-813727-7 | ||
035 | |a (DE-627)1031901787 | ||
035 | |a (DE-599)GBV1031901787 | ||
035 | |a (ELSEVIER)on1052566533 | ||
035 | |a (EBP)027155528 | ||
040 | |a DE-627 |b eng |c DE-627 |e rda | ||
041 | |a eng | ||
044 | |c XA-NL | ||
050 | 0 | |a RM171 | |
060 | 0 | |a WB 356 | |
072 | 7 | |a MED 071000 |2 bisacsh | |
072 | 7 | |a MED 071000 |2 bisacsh | |
245 | 1 | 0 | |a Transfusion medicine and hemostasis |b clinical and laboratory aspects |c edited by Beth H. Shaz, Christopher D. Hillyer, Morayma Reyes Gil |
250 | |a Third edition | ||
264 | 1 | |a Amsterdam, Netherlands |b Elsevier |c 2018 | |
300 | |a 1 Online-Ressource (1 online resource) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Includes index | ||
520 | |a Current Good Manufacturing PracticesLaboratory Laws and Regulations; Other Regulatory Agencies; Blood Banking; Chapter 4. Role of the Physician in the Blood Center; Blood Center Table of Organization; Donation Process; Chapter 5. Blood Donation; Blood Donors; Donation Process; Technical Aspects; Chapter 6. Apheresis Blood Component Collections; RBC Apheresis Collections; Plateletpheresis Collections; Plasmapheresis Collections; Chapter 7. Recipient-Specific Blood Donation; Exceptional Medical Need; Directed Donation; Autologous Donation; Chapter 8. Adverse Donor Reactions | ||
520 | |a Complications of Whole Blood DonationComplications of Apheresis Donations; Approach to the Donor and Donation Process; Prevention; Biovigilance and Reporting; Component Manufacturing; Chapter 9. Component Preparation and Manufacturing; Whole Blood; Component Manufacturing; RBC Components; Plasma Components; Cryoprecipitate; Cryoprecipitate-Reduced Plasma; Platelet Components; Granulocytes; Component Labeling; Donor Testing; Chapter 10. Serologic Testing of Donor Products; ABO Group Typing; D Antigen Phenotype; Antibody Screening for the Presence of Unexpected RBC Antibodies | ||
520 | |a Chapter 14. Hepatitis C Virus ScreeningDetermination of Need and Requirement for Testing; Donor Management; Chapter 15. West Nile Virus Screening; Determination of Need and Requirement for Testing; Donor Management; Chapter 16. Zika Virus Screening; Infection; Determination of Need and Requirement for Testing; Blood Unit Management; Donor Management; Chapter 17. Babesia Screening; Description; Infection; Determination of Need and Requirement for Testing; Blood Unit Management; Donor Management; Chapter 18. Syphilis, Human T-Cell Lymphotropic Virus, and Chagas Screening; Syphilis | ||
520 | |a Intro; Title page; Table of Contents; Copyright; List of Contributors; About the Editors; Preface; PART I. Blood Banking and Transfusion Medicine; Chapter 1. Introduction to Blood Banking and Transfusion Medicine; Blood Transfusion History; Blood Industry; Discipline; Chapter 2. Quality Principles in Transfusion Medicine; Basic Principles; Quality Management Systems; Process Improvement; New Role of Quality; Chapter 3. Regulatory Issues in Transfusion Medicine; Regulation Versus Accreditation; The Food and Drug Administration; Registration and Licensure; Inspections and Compliance Actions | ||
520 | |a Phenotyping RBC ProductsAntibody Titer Anti-A, Anti-B; International; Chapter 11. Overview of Infectious Disease Testing; Background; Approach to Testing; Determination of Need and Requirement for Testing; Selection of Testing Methodology; Biology of Infection and Testing Strategies; Product and Donor Management; Chapter 12. Human Immunodeficiency Virus Screening; Description; Determination of Need and Requirement for Testing; Blood Unit Management; Donor Management; Chapter 13. Hepatitis B Virus Screening; Determination of Need and Requirement for Testing; Donor Management | ||
533 | |a Online-Ausg. | ||
650 | 0 | |a Blood |x Transfusion | |
650 | 0 | |a Blood |x Collection and preservation | |
650 | 0 | |a Hemostasis | |
650 | 0 | |a Blood |x Transfusion | |
650 | 0 | |a Blood |x Collection and preservation | |
650 | 0 | |a Hemostasis | |
650 | 2 | |a Hematologic Diseases |x therapy | |
650 | 2 | |a Hematologic Tests |x methods | |
650 | 2 | |a Hematologic Tests |x methods | |
650 | 2 | |a Hematologic Diseases |x therapy | |
650 | 2 | |a Blood Transfusion | |
650 | 2 | |a Hemostasis | |
650 | 2 | |a Blood Banks | |
650 | 2 | |a Blood Preservation | |
650 | 4 | |a Blood ; Collection and preservation | |
650 | 4 | |a Hemostasis | |
650 | 4 | |a Hemostatics | |
650 | 4 | |a MEDICAL ; Pharmacology | |
650 | 4 | |a Blood ; Transfusion | |
650 | 4 | |a Sang - Transfusion | |
650 | 4 | |a Sang - Collecte et conservation | |
650 | 4 | |a H�emostase | |
655 | 0 | |a Electronic books | |
700 | 1 | |a Shaz, Beth |e herausgeberin |4 edt | |
700 | 1 | |a Hillyer, Christopher D. |e herausgeberin |4 edt | |
700 | 1 | |a Gil, Morayma Reyes |e herausgeberin |4 edt | |
776 | 1 | |z 0128137266 | |
776 | 1 | |z 9780128137260 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Transfusion medicine and hemostasis |d Amsterdam, Netherlands : Elsevier, [2019] |z 9780128137260 |
856 | 4 | 0 | |u https://www.sciencedirect.com/science/book/9780128137260 |m X:ELSEVIER |x Verlag |z lizenzpflichtig |3 Volltext |
912 | |a GBV-33-Freedom |b 2021 | ||
912 | |a GBV-33-EBS-MRI | ||
912 | |a GBV-33-EBS-ZHB | ||
912 | |a GBV-33-Freedom |b 2022 | ||
912 | |a ZDB-33-EBS | ||
912 | |a ZDB-33-ESD | ||
912 | |a GBV-33-EBS-MHH | ||
912 | |a GBV_ILN_22 | ||
912 | |a ISIL_DE-18 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22_i06404 | ||
912 | |a GBV_ILN_62 | ||
912 | |a ISIL_DE-28 | ||
912 | |a GBV_ILN_65 | ||
912 | |a ISIL_DE-3 | ||
912 | |a GBV_ILN_74 | ||
912 | |a ISIL_DE-354 | ||
912 | |a GBV_ILN_105 | ||
912 | |a ISIL_DE-841 | ||
951 | |a BO | ||
953 | |2 045F |a 615/.39 | ||
980 | |2 22 |1 01 |x 0018 |b 3615580818 |h h64 Elsevier Biomedical Science and Medicine |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y zi06404 |z 30-03-20 | ||
980 | |2 62 |1 01 |x 0028 |b 1830666290 |h ACQ |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y z |z 06-12-18 | ||
980 | |2 65 |1 01 |x 0003 |b 4117205226 |c 03 |f --%%-- |d ebook |e --%%-- |j --%%-- |h Elsevier-EBS-Kauf |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots. |y k3o |z 13-04-22 | ||
980 | |2 74 |1 01 |x 0354 |b 3563946558 |c 09 |f E-Bibl |d EK 0062 |e --%%-- |j --%%-- |h ACQ |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |y ze |z 11-12-19 | ||
980 | |2 105 |1 01 |x 0841 |b 4074377276 |h OLR-ELV-TEST |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt. |k Testzugang ZHB Lübeck |y z |z 26-02-22 | ||
981 | |2 22 |1 01 |x 0018 |y Volltextzugang Campus |r https://www.sciencedirect.com/science/book/9780128137260 | ||
981 | |2 22 |1 01 |x 0018 |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus |r http://emedien.sub.uni-hamburg.de/han/ScienceDirectBookseriesUKE/www.sciencedirect.com/science/book/9780128137260 | ||
981 | |2 62 |1 01 |x 0028 |r https://www.sciencedirect.com/science/book/9780128137260 | ||
981 | |2 65 |1 01 |x 0003 |y Volltextzugang Campus |r https://www.sciencedirect.com/science/book/9780128137260 | ||
981 | |2 74 |1 01 |x 0354 |y Volltext, Campuszugriff |r https://www.sciencedirect.com/science/book/9780128137260 | ||
981 | |2 74 |1 01 |x 0354 |y Volltext, Externer Zugriff |r http://mhh.hh-han.com/han/ebs/www.sciencedirect.com/science/book/9780128137260 | ||
981 | |2 105 |1 01 |x 0841 |r https://www.sciencedirect.com/science/book/9780128137260 | ||
985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
985 | |2 74 |1 01 |x 0354 |a EK 0062 | ||
985 | |2 74 |1 01 |x 0354 |a EM 4467 | ||
995 | |2 22 |1 01 |x 0018 |a h64 Elsevier Biomedical Science and Medicine | ||
995 | |2 62 |1 01 |x 0028 |a ACQ | ||
995 | |2 62 |1 01 |x 0028 |a OLR-Elsevier-EBS | ||
995 | |2 65 |1 01 |x 0003 |a Elsevier-EBS-Kauf | ||
995 | |2 65 |1 01 |x 0003 |a ACQ | ||
995 | |2 74 |1 01 |x 0354 |a ACQ | ||
995 | |2 74 |1 01 |x 0354 |a OLR-EBS | ||
995 | |2 105 |1 01 |x 0841 |a OLR-ELV-TEST |